Profile: Neptune Technologies & Bioressources Inc (NEPT.O)

NEPT.O on Consolidated Issue listed on NASDAQ Capital Market

1.92USD
19 Dec 2014
Price Change (% chg)

$-0.08 (-4.00%)
Prev Close
$2.00
Open
$1.98
Day's High
$1.98
Day's Low
$1.88
Volume
99,322
Avg. Vol
154,156
52-wk High
$3.61
52-wk Low
$1.11

Search Stocks
Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune’s distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).

Company Address

Neptune Technologies & Bioressources Inc

545 Prom du Centropolis Suite 10
LAVAL   QC   H7T 0A3
P: +1450.6872262
F: +1450.6872272

Search Stocks